Wednesday, 20 May 2020

Strides Pharma to conduct trials in India for potential COVID-19 drug

Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.


from Reuters: Health https://ift.tt/2Xdqku8

No comments:

Post a Comment